Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 10Gastrointestinal 3Breast 3Thoracic 1Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Lung Neoplasms 5Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Smoking 1Skin Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lung Cancer Screening 1Endometrial Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 30Nivolumab 12Carboplatin 6atezolizumab 5Trastuzumab 5aldesleukin 4Specimen Handling 4Paclitaxel 4Magnetic Resonance Spectroscopy 4Ipilimumab 4Docetaxel 4Cyclophosphamide 4Cisplatin 4Bevacizumab 4spartalizumab 3fludarabine 3durvalumab 3Polymerase Chain Reaction 3Irinotecan 3Interleukin-2 3Gene Expression Profiling 3Blood Specimen Collection 3Biopsy 3zimberelimab 2tisotumab vedotin 2tislelizumab 2sargramostim 2osimertinib 2enzalutamide 2cemiplimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Mass Screening × Thoracic × Clear all
NCT00859768 2011-03-08

The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients

Netherlands Open University

Phase NA Completed
568 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡